{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:41:49Z","timestamp":1793914909985,"version":"4.8.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pharmthera.2021.107843","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T21:59:12Z","timestamp":1617227952000},"page":"107843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":532,"special_numbering":"C","title":["Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms"],"prefix":"10.1016","volume":"225","author":[{"given":"Kai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Youn","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.107843_bb0005","doi-asserted-by":"crossref","first-page":"100407","DOI":"10.1016\/j.imr.2020.100407","article-title":"Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines","volume":"9","author":"Ang","year":"2020","journal-title":"Integrative Medicine Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0015","doi-asserted-by":"crossref","first-page":"116346","DOI":"10.1016\/j.carbpol.2020.116346","article-title":"The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic","volume":"240","author":"Cao","year":"2020","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0020","doi-asserted-by":"crossref","first-page":"110281","DOI":"10.1016\/j.biopha.2020.110281","article-title":"Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming","volume":"129","author":"Chen","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0025","first-page":"12","article-title":"A novel combination of vitamin C, Curcumin and Glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: A perspective from system biology analysis","author":"Chen","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jep.2017.10.001","article-title":"Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis","volume":"211","author":"Chen","year":"2018","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ptr.1485","article-title":"Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS","volume":"18","author":"Chen","year":"2004","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0040","first-page":"150","article-title":"Clinical effectiveness and case analysis in 54 NCP patients treated with Lanhuaqingwen granules","volume":"15","author":"Cheng","year":"2020","journal-title":"World Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0045","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.intimp.2006.01.011","article-title":"Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression","volume":"6","author":"Cheng","year":"2006","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0050","author":"ChinaDaily"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0055","author":"ChinaDaily"},{"issue":"7647","key":"10.1016\/j.pharmthera.2021.107843_bb0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/bmj.39527.472303.4E","article-title":"The yellow emperor\u2019s classic of internal medicine","volume":"336","author":"Curran","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0065","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0070","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: Database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0075","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/CM9.0000000000000819","volume":"133","author":"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)","year":"2020","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12906-017-1585-7","article-title":"The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function","volume":"17","author":"Ding","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0085","first-page":"1473","article-title":"Clinical observation of Jinhua Qinggan granule in treating pneumonia infected by novel coronavirus","volume":"61","author":"Duan","year":"2020","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0090","first-page":"1","article-title":"Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes","author":"Elmezayen","year":"2020","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0095","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1142\/S0192415X20500640","article-title":"Application of Chinese medicine in the management of critical conditions: A review on sepsis","volume":"48","author":"Fan","year":"2020","journal-title":"The American Journal of Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fphar.2020.00746","article-title":"Identification of a pharmacological biomarker for the bioassay-based quality control of a thirteen-component TCM formula (Lianhua Qingwen) used in treating influenza A virus (H1N1) infection","volume":"11","author":"Gao","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0105","first-page":"162","article-title":"Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing injection","volume":"29","author":"Gao","year":"2013","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0110","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1039\/c0np00005a","article-title":"Anti-influenza agents from traditional Chinese medicine","volume":"27","author":"Ge","year":"2010","journal-title":"Natural Product Reports"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0115","first-page":"1685","article-title":"Exploring active compounds of Jinhua qinggan granules for prevention of covid-19 based on network pharmacology and molecular docking","volume":"51","author":"Gong","year":"2020","journal-title":"Chinese Traditional and Herbal Drugs"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0120","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.21037\/apm-20-1478","article-title":"Xuebijing injection in the treatment of COVID-19: A retrospective case-control study","volume":"9","author":"Guo","year":"2020","journal-title":"Annals of Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0125","first-page":"398","article-title":"Potential mechanism of xuebijing injection in treatment of coronavirus pneumonia based on network pharmacology and molecular docking","volume":"37","author":"He","year":"2020","journal-title":"The Chinese Journal of Modern Applied Pharmacy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.15537\/smj.2015.2.9895","article-title":"Efficacy of Xuebijing for coagulopathy in patients with sepsis","volume":"36","author":"Hou","year":"2015","journal-title":"Saudi Medical Journal"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jep.2012.05.061","article-title":"Mechanism by which Ma-Xing-Shi-Gan-Tang inhibits the entry of influenza virus","volume":"143","author":"Hsieh","year":"2012","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0145","doi-asserted-by":"crossref","first-page":"5157089","DOI":"10.1155\/2020\/5157089","article-title":"Efficacy of Lianhua Qingwen compared with conventional drugs in the treatment of common pneumonia and COVID-19 pneumonia: A meta-analysis","volume":"2020","author":"Hu","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0150","article-title":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial","volume":"2020","author":"Hu","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0155","doi-asserted-by":"crossref","first-page":"11224","DOI":"10.18632\/aging.103370","article-title":"Treatment strategies of hospitalized patients with coronavirus disease-19","volume":"12","author":"Huang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0160","doi-asserted-by":"crossref","first-page":"731765","DOI":"10.1155\/2015\/731765","article-title":"Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS","volume":"2015","author":"Jia","year":"2015","journal-title":"The Scientific World Journal"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0165","first-page":"1275","article-title":"Study on the active components in the adjuvant treatment of novel coronavirus pneumonia (covid-19) with Jinhua Qinggan granules based on network pharmacology and molecular docking","volume":"43","author":"Jimilihan","year":"2020","journal-title":"Journal of Chinese Medicinal Materials"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40779-020-00270-8","article-title":"Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)","volume":"7","author":"Jin","year":"2020","journal-title":"Military Medical Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0180","first-page":"552","article-title":"Mechanism of XueBiJing injection on treatment of coronavirus disease 2019 based on network pharmacology","volume":"22","author":"Kong","year":"2020","journal-title":"Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0185","article-title":"Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B","volume":"2019","author":"Kong","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0190","first-page":"909","article-title":"Pharmacological mechanism and network pharmacology research of Huashibaidu formula in treating COVID-19","volume":"32","author":"Lai","year":"2020","journal-title":"Natural Product Research and Development"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1142\/S0192415X05002965","article-title":"Using herbal medicine as a means of prevention experience during the SARS crisis","volume":"33","author":"Lau","year":"2005","journal-title":"The American Journal of Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0205","first-page":"1631","article-title":"Treating influenza patients of wind-heat affecting Fei syndrome by Jinhua Qinggan granule: A double-blinded randomized control trial","volume":"33","author":"Li","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41401-020-0438-y","article-title":"Overview of therapeutic drug research for COVID-19 in China","volume":"41","author":"Li","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0215","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.biopha.2017.10.065","article-title":"Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats","volume":"96","author":"Li","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcma.2015.10.009","article-title":"Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis","volume":"79","author":"Li","year":"2016","journal-title":"Journal of the Chinese Medical Association"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11684-020-0801-x","article-title":"The role played by traditional Chinese medicine in preventing and treating COVID-19 in China","volume":"14","author":"Li","year":"2020","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0230","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0235","doi-asserted-by":"crossref","first-page":"105036","DOI":"10.1016\/j.phrs.2020.105036","article-title":"Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019","volume":"160","author":"Li","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0240","article-title":"Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6","volume":"41","author":"Liang","year":"2020","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0245","doi-asserted-by":"crossref","first-page":"112656","DOI":"10.1016\/j.jep.2020.112656","article-title":"Shegan-Mahuang decoction ameliorates asthmatic airway hyperresponsiveness by downregulating Th2\/Th17 cells but upregulating CD4+FoxP3+ Tregs","volume":"253","author":"Lin","year":"2020","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0250","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/14756366.2021.1873977","article-title":"Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like proteasein vitro","volume":"36","author":"Liu","year":"2021","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0255","doi-asserted-by":"crossref","first-page":"21146","DOI":"10.1038\/srep21146","article-title":"BATMAN-TCM: A bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0260","first-page":"467","article-title":"Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients","volume":"40","author":"Liu","year":"2020","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13020-020-00375-1","article-title":"Reflections on treatment of COVID-19 with traditional Chinese medicine","volume":"15","author":"Luo","year":"2020","journal-title":"Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0270","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","article-title":"Can Chinese medicine be used for prevention of Corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs","volume":"26","author":"Luo","year":"2020","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0275","doi-asserted-by":"crossref","first-page":"105073","DOI":"10.1016\/j.phrs.2020.105073","article-title":"The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2","volume":"160","author":"Ma","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0280","first-page":"243","article-title":"Study on treatment of influenza A H1N1 induced severe pneumonia by Xuebijing injection","volume":"10","author":"Ma","year":"2015","journal-title":"World Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0285","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001089","article-title":"Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy","volume":"8","author":"Montesarchio","year":"2020","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0295","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0300","author":"NHC"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0305","doi-asserted-by":"crossref","first-page":"7493281","DOI":"10.1155\/2020\/7493281","article-title":"Network pharmacology analysis to identify phytochemicals in traditional Chinese medicines that may regulate ACE2 for the treatment of COVID-19","volume":"2020","author":"Niu","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0310","author":"Notice"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0315","doi-asserted-by":"crossref","first-page":"198057","DOI":"10.1016\/j.virusres.2020.198057","article-title":"Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China","volume":"286","author":"Pan","year":"2020","journal-title":"Virus Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0320","first-page":"1664","article-title":"Clinical efficacy of different doses of Jinhuaqinggan granule on influenza and serum levels of cytokines","volume":"44","author":"Qi","year":"2016","journal-title":"Modern Medical Journal"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0325","doi-asserted-by":"crossref","first-page":"104743","DOI":"10.1016\/j.phrs.2020.104743","article-title":"Traditional Chinese medicine for COVID-19 treatment","volume":"155","author":"Ren","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0330","first-page":"1225","article-title":"Study on treatment of \u201ccytokine storm\u201d by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway","volume":"45","author":"Ren","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1934578X20947213","article-title":"Evidence-based complementary and alternative medicine exploring active components and mechanism of Jinhua Qinggan granules in treatment of covid-19 based on virus-host interaction","volume":"15","author":"Ren","year":"2020","journal-title":"Natural Product Communications"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: A database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"Journal of Cheminformatics"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0345","author":"Sekiou","year":"2020","journal-title":"Chemrxiv"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0350","first-page":"622","article-title":"The potential molecular mechanism of active compounds binding SARS-CoV-2 specific target proteins in Huaqing granules treat COVID-19 based on network pharmacology and high-throughput molecular docking fellowship","volume":"22","author":"Shen","year":"2020","journal-title":"Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0355","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajem.2016.11.007","article-title":"Xuebijing in the treatment of patients with sepsis","volume":"35","author":"Shi","year":"2017","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0360","doi-asserted-by":"crossref","first-page":"153367","DOI":"10.1016\/j.phymed.2020.153367","article-title":"Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial","volume":"81","author":"Shi","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0365","doi-asserted-by":"crossref","first-page":"105290","DOI":"10.1016\/j.phrs.2020.105290","article-title":"Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study","volume":"161","author":"Shi","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0370","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201ccytokine storm\u201d relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0375","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1097\/CCM.0000000000003842","article-title":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: A randomized controlled trial","volume":"47","author":"Song","year":"2019","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0380","doi-asserted-by":"crossref","first-page":"106080","DOI":"10.1016\/j.ijantimicag.2020.106080","article-title":"COVID-19 treatment: Close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)","volume":"56","author":"Song","year":"2020","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0385","article-title":"Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro","author":"Su","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0390","first-page":"2050","article-title":"The molecular mechanism of treating COVID-19 with Huashi Baidu formula based on network pharmacology","volume":"43","author":"Sun","year":"2020","journal-title":"Journal of Chinese Medicinal Materials"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0395","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/03639045.2020.1788070","article-title":"Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19","volume":"46","author":"Tao","year":"2020","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0400","first-page":"253","article-title":"Complementary and alternative medicine is expected to make greater contribution in controlling the prevalence of influenza","volume":"7","author":"Tao","year":"2013","journal-title":"Bioscience Trends"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13020-020-00326-w","article-title":"The potential insights of Traditional Chinese Medicine on treatment of COVID-19","volume":"15","author":"Tong","year":"2020","journal-title":"Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0410","author":"Tu"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0415","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ccell.2020.09.019","article-title":"Cytokine storms in cancer and COVID-19","volume":"38","author":"Turnquist","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/0003-4819-155-4-201108160-00005","article-title":"Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: A randomized trial","volume":"155","author":"Wang","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0425","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00134-020-06065-8","article-title":"IL-6 may be a good biomarker for earlier detection of COVID-19 progression","volume":"46","author":"Wang","year":"2020","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0430","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/C5MB00448A","article-title":"A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components","volume":"12","author":"Wang","year":"2016","journal-title":"Molecular BioSystems"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0435","first-page":"273","article-title":"Montelukast combined with Shegan Mahuang Tang for treating of 86 patients with cough variant asthma","volume":"18","author":"Wang","year":"2012","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0440","article-title":"The molecular mechanism of Xuanfei Baidu formula in the treatment of COVID-19 antiviral effect based on network pharmacology and molecular docking","author":"Wang","year":"2020","journal-title":"Journal of Hainan Medical University"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.107843_bb0445","first-page":"13","article-title":"Clinical observation of qingfeipaidu decoction in the treatment of covid-19","volume":"36","author":"Wang","year":"2020","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0450","first-page":"2249","article-title":"Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology","volume":"45","author":"Wang","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0455","first-page":"426","article-title":"Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019","volume":"32","author":"Wen","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0460","author":"WHO"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0465","first-page":"374","article-title":"Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology","volume":"55","author":"Wu","year":"2020","journal-title":"Acta Pharmaceutica Sinica"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0470","doi-asserted-by":"crossref","first-page":"105101","DOI":"10.1016\/j.phrs.2020.105101","article-title":"Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines","volume":"160","author":"Wu","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0475","author":"Wu"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12949","article-title":"Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19","volume":"53","author":"Xia","year":"2020","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0485","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","article-title":"Bioactive natural compounds against human coronaviruses: A review and perspective","volume":"10","author":"Xian","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0490","doi-asserted-by":"crossref","first-page":"105126","DOI":"10.1016\/j.phrs.2020.105126","article-title":"Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial","volume":"161","author":"Xiao","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0495","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010971","article-title":"Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population: A meta-analysis","volume":"97","author":"Xiao","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.107843_bb0500","first-page":"28","article-title":"Study of molecular mechanism of Huashibaidu decoction on COVID-19 based on network pharmacology and molecular docking technology","volume":"36","author":"Xie","year":"2020","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0505","doi-asserted-by":"crossref","first-page":"110500","DOI":"10.1016\/j.biopha.2020.110500","article-title":"Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment","volume":"129","author":"Xin","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0510","doi-asserted-by":"crossref","first-page":"100489","DOI":"10.1016\/j.imr.2020.100489","article-title":"Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: A pilot randomized clinical trial","volume":"9","author":"Xiong","year":"2020","journal-title":"Integrative Medicine Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0515","doi-asserted-by":"crossref","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","article-title":"TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis","volume":"41","author":"Xue","year":"2013","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0520","first-page":"26","article-title":"Traditional Chinese Medicine in treating influenza A (H1N1)\u2014Jinhua Qinggan granules","author":"Yan","year":"2010","journal-title":"Family Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0525","doi-asserted-by":"crossref","first-page":"3196375","DOI":"10.1155\/2020\/3196375","article-title":"Lianhua-Qingwen displays antiviral and anti-inflammatory activity and synergistic effects with Oseltamivir against influenza B virus infection in the mouse model","volume":"2020","author":"Yang","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0530","doi-asserted-by":"crossref","first-page":"104820","DOI":"10.1016\/j.phrs.2020.104820","article-title":"Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study","volume":"157","author":"Yang","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0535","first-page":"672","article-title":"Material basis research of anti-COVID-19 Huashibaidu granule gormula","volume":"22","author":"Yang","year":"2020","journal-title":"Modern Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0540","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jep.2015.04.011","article-title":"Wuling San protects kidney dysfunction by inhibiting renal TLR4\/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice","volume":"169","author":"Yang","year":"2015","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0545","first-page":"8","article-title":"Retrospective clinical analysis on treatment of coronavirus disease 2019 with traditional chinese medicine lianhua qingwen","volume":"26","author":"Yao","year":"2020","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0550","article-title":"Theoretical study of the anti-NCP molecular mechanism of Traditional Chinese Medicine Lianhua-Qingwen Formula (LQF)","author":"Ye","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0555","doi-asserted-by":"crossref","first-page":"949254","DOI":"10.1155\/2014\/949254","article-title":"Treatment effects of xuebijing injection in severe septic patients with disseminated intravascular coagulation","volume":"2014","author":"Yin","year":"2014","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0560","first-page":"1042","article-title":"Effects of lianhua qingwen granules plus arbidol on treatment of mild corona virus disease-19","volume":"55","author":"Yu","year":"2020","journal-title":"Chinese Pharmaceutical Journal"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238828","article-title":"Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials","volume":"15","author":"Zeng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0570","author":"Zhang"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0575","first-page":"964","article-title":"Clinical observation of Xuebijing in the treatment of COVID-19","volume":"40","author":"Zhang","year":"2020","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0580","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajem.2020.03.046","article-title":"Is traditional Chinese medicine useful in the treatment of COVID-19?","volume":"38","author":"Zhang","year":"2020","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0585","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0590","first-page":"673","article-title":"Effect of treatment with xuebijing injection on serum inflammatory mediators and th1\/2 of spleen in rats with sepsis","volume":"18","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0595","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","article-title":"Viral and host factors related to the clinical outcome of COVID-19","volume":"583","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0600","first-page":"1908","article-title":"The curative mechanism of Maxingshigan decoction on cytokine storm of COVID-19 pneumonia based on network pharmacology","volume":"15","author":"Zhang","year":"2020","journal-title":"World Chinese Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0605","article-title":"Protocol for developing clinical practice guidelines on traditional Chinese medicine therapy for influenza","author":"Zhao","year":"2020","journal-title":"Annals of Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0610","article-title":"Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19","author":"Zhao","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0615","first-page":"25","article-title":"Efficacy of Lianhuaqingwen capsule compared with oseltamivir for influenza A virus infection: A meta-analysis of randomized, controlled trials","volume":"20","author":"Zhao","year":"2014","journal-title":"Alternative Therapies in Health and Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0620","doi-asserted-by":"crossref","first-page":"529458","DOI":"10.1155\/2013\/529458","article-title":"Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents","volume":"2013","author":"Zheng","year":"2013","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0625","doi-asserted-by":"crossref","first-page":"117","DOI":"10.21037\/atm.2018.09.26","article-title":"A real-world study on adverse drug reactions to Xuebijing injection: Hospital intensive monitoring based on 93 hospitals (31,913 cases)","volume":"7","author":"Zheng","year":"2019","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.107843_bb0630","first-page":"3035","article-title":"Identification and attribution of chemical constituents of Qingfei Paidu Decoction based on UHPLC-LTQ-Orbitrap-MS technology","volume":"45","author":"Zhou","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:19:29Z","timestamp":1759011569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":126,"alternative-id":["S0163725821000450"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107843","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107843"}}